Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15774788 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
Condition: Breast Cancer
Interventions: Other: Doxorubicin followed by Paclitaxel;   Other: Paclitaxel followed by Doxorubicin

Indicates status has not been verified in more than two years